IriSys - About the company
IriSys is an acquired company based in San Diego (United States), founded in 1996 by Gerald Yakatan. It operates as a CDMO specializing in the development of a wide range of dosage forms. IriSys has raised $6.3M in funding. The company has 373 active competitors, including 15 funded and 91 that have exited. Its top competitors include companies like Concord Biotech, Aizant and Almac Group.
Company Details
IriSys provides contract pharmaceutical product development and manufacturing services specialising in formulation development, cGMP (current Good Manufacturing Practices) manufacturing of clinical trial materials and commercial pharmaceutical products, and consulting related to the drug development process. IriSys’ scientific and regulatory experience includes having moved more than 100 drug products from discovery to Phase I, Phase II, Phase III and into commercialization. Their services cater to the development of oral, topical and injectable dosage forms (including microsphere-based and lyophilized dosage forms).
- Website
- irisys.com
- Registered Address
- San Diego, California
Key Metrics
Founded Year
1996
Location
San Diego, United States
Stage
Acquired
Total Funding
$6.3M in 1 round
Latest Funding Round
Ranked
36th among 373 active competitors
Employee Count
59 as on Dec 31, 2022
Similar Companies
Exit Details
Acquired by Recro (Aug 13, 2021)
Legal entities associated with IriSys
IriSys is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Irisys, Llc CIN: 472796381 , United States, Active | Dec 26, 999 | - | 59 (As on Dec 31, 2020) | - |
IriSys's acquisition details
Click here to take a look at IriSys's acquisition in detail
Sign up to download IriSys' company profile
IriSys's funding and investors
IriSys has raised a total funding of $6.3M over 1 round.
Here is the list of recent funding rounds of IriSys:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 11, 2015 | 3767217 | Series A | 2588830 | 3884295 | 4068634 | 4541926 |
Access funding benchmarks and valuations. Sign up today!View details of IriSys's funding rounds and investors
IriSys' founders and board of directors
Founder? Claim ProfileThe founders of IriSys is Gerald Yakatan.
Here are the details of IriSys' key team members:
- Gerald Yakatan: Chairman, CEO and Founder of IriSys.
View details of IriSys's Founder profiles and Board Members
IriSys' employee count trend
IriSys has 59 employees as of Dec 22. The total employee count is 18.0% more than what it was in Dec 21. Here is IriSys's employee count trend over the years:
Uncover IriSys' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
IriSys's Competitors and alternates
Top competitors of IriSys include Concord Biotech, Aizant and Almac Group. Here is the list of Top 10 competitors of IriSys, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Concord Biotech 2000, Ahmedabad (India), Public | CDMO focused on manufacturing API | - | 65/100 | |
2nd | Company offering contract development services for small molecules | $16.8M | 60/100 | ||
3rd | Almac Group 2001, Craigavon (United Kingdom), Series D | CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development | $339M | 57/100 | |
4th |  Nucleus RadioPharma 2022, Rochester (United States), Series A | CDMO focused on providing of radiopharmaceuticals manufacturing and supply chain services | $72.1M | 54/100 | |
5th | Indoco Remedies 1947, Mumbai (India), Public | Provider of APIs manufacturing and formulation services | - | 54/100 | |
6th |  Wanbury Limited 1990, Mumbai (India), Public | Manufacturer of anti-diabetic drugs | - | - | 53/100 |
7th | Development and manufacturing of niche pharmaceutical products for the generic industry | $2.74M | 53/100 | ||
8th | Turnkey solutions for drug development, manufacturing and regulatory approvals | - | 52/100 | ||
9th | CDMO focused on amino acids and small molecules | - | - | 51/100 | |
10th | Aptuit 2004, Greenwich (United States), Acquired | Pioneering drug discovery and development, accelerating concept to cure | $14.2M | 50/100 | |
36th | IriSys 1996, San Diego (United States), Acquired | CDMO specializing in the development of a wide range of dosage forms | $6.3M | - | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on IriSys's competitors? Click here to see the top ones
IriSys's Investments and acquisitions
IriSys has made no investments or acquisitions yet.
Reports related to IriSys
Here is the latest report on IriSys's geography:
News related to IriSys
•
•
Patent Issued to IRISYS, LLC for a New Liposomal Anticancer Drug Delivery SystemPR Newswire•Jun 18, 2021•IriSys
•
•
•
•
•
IriSys clinical trial material manufacturing contract upped to $6mOutsourcing-Pharma•Apr 24, 2017•IriSys
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about IriSys
Explore our recently published companies
- Wisdom Square Technologies - New Hyde Park based, 2008 founded, Unfunded company
- Fruverpack - Almoradi based, 1992 founded, Unfunded company
- AERA - Bouxwiller based, 1979 founded, Unfunded company
- Divine Hindu - Ujjain based, 2023 founded, Unfunded company
- Globaldigitalpartner.com - 2013 founded, Unfunded company
- OROK - Bourgoin Jallieu based, 2018 founded, Deadpooled company
